CN111686225A - A Chinese medicinal composition for breast health protection, and its preparation method - Google Patents
A Chinese medicinal composition for breast health protection, and its preparation method Download PDFInfo
- Publication number
- CN111686225A CN111686225A CN202010666900.5A CN202010666900A CN111686225A CN 111686225 A CN111686225 A CN 111686225A CN 202010666900 A CN202010666900 A CN 202010666900A CN 111686225 A CN111686225 A CN 111686225A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- health care
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 230000036541 health Effects 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 210000000481 breast Anatomy 0.000 title claims description 24
- 239000003814 drug Substances 0.000 claims abstract description 82
- 238000001035 drying Methods 0.000 claims abstract description 29
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 19
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 19
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 18
- 239000000463 material Substances 0.000 claims abstract description 18
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 16
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 16
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 16
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 15
- 239000012535 impurity Substances 0.000 claims abstract description 15
- 235000008113 selfheal Nutrition 0.000 claims abstract description 15
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 14
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 12
- 229940126680 traditional chinese medicines Drugs 0.000 claims abstract description 9
- 241000331983 Arisaema consanguineum Species 0.000 claims abstract description 6
- 241000245665 Taraxacum Species 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 238000007873 sieving Methods 0.000 claims description 8
- 238000004140 cleaning Methods 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- 241000489492 Arisaema Species 0.000 claims description 3
- 244000164480 Curcuma aromatica Species 0.000 claims description 2
- 235000003398 Curcuma aromatica Nutrition 0.000 claims description 2
- 210000000941 bile Anatomy 0.000 claims description 2
- 238000012216 screening Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 25
- 201000010099 disease Diseases 0.000 abstract description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 14
- 210000005075 mammary gland Anatomy 0.000 abstract description 13
- 230000002265 prevention Effects 0.000 abstract description 4
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 230000006806 disease prevention Effects 0.000 abstract description 2
- 230000000857 drug effect Effects 0.000 abstract 2
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 23
- 239000008280 blood Substances 0.000 description 23
- 210000004369 blood Anatomy 0.000 description 23
- 230000036407 pain Effects 0.000 description 23
- 210000004185 liver Anatomy 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- 230000008961 swelling Effects 0.000 description 9
- 201000000736 Amenorrhea Diseases 0.000 description 6
- 206010001928 Amenorrhoea Diseases 0.000 description 6
- 231100000540 amenorrhea Toxicity 0.000 description 6
- 208000004998 Abdominal Pain Diseases 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 206010010726 Conjunctival oedema Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 208000004396 mastitis Diseases 0.000 description 3
- 210000004304 subcutaneous tissue Anatomy 0.000 description 3
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 208000030270 breast disease Diseases 0.000 description 2
- 201000001352 cholecystitis Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000000762 glandular Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000000197 Acute Cholecystitis Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 206010006322 Breath holding Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008614 Cholecystitis acute Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010021518 Impaired gastric emptying Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 241000212322 Levisticum officinale Species 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000001407 Vascular Headaches Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229940108928 copper Drugs 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000001288 gastroparesis Diseases 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 239000001645 levisticum officinale Substances 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000001055 magnesium Nutrition 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 208000023482 precordial pain Diseases 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 208000018316 severe headache Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the technical field of traditional Chinese medicines, which is used for health care and disease prevention of female mammary gland, in particular to a traditional Chinese medicine composition for mammary gland health care and a preparation method thereof, wherein the traditional Chinese medicine composition comprises the following components, by weight, 22-25 parts of dandelion, 15-18 parts of prepared arisaema consanguineum schott, 10-15 parts of radix curcumae, 10-15 parts of angelica sinensis, 10-15 parts of selfheal, 10-15 parts of ligusticum wallichii, 10-15 parts of safflower and 10-15 parts of myrrh; the preparation method comprises the steps of removing impurities, drying, preparing materials and crushing in sequence to obtain the powdery traditional Chinese medicine composition, so that the problems of single drug effect and poor drug effect of the existing medicine are solved, the traditional Chinese medicine composition has good curative effect and prevention effect on various diseases of mammary gland by mutual synergistic cooperation of the components and control of the dosage ratio of the components, the treatment and health care effects are obvious, the treatment period is short, meanwhile, the preparation method of the traditional Chinese medicine composition is simple, the preparation conditions are easy to reach, and the popularization value is high.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, is used for health care and disease prevention of female mammary glands, and particularly relates to a traditional Chinese medicine composition for health care of mammary glands and a preparation method thereof.
Background
The mammary gland is positioned between the superficial layer and the deep layer of the subcutaneous superficial fascia, the superficial fascia extends to the mammary tissue to form cord-shaped lobular intervals, one end of the lobular intervals is connected with the pectoralis fascia, the other end of the lobular intervals is connected with the skin, the mammary gland is fixed in the subcutaneous tissue of the chest, the mammary gland consists of 15-20 glandular lobes, each glandular lobe is divided into a plurality of lobular lobes, each lobular lobe consists of 10-100 acinus, the acinus are closely arranged around the small lactiferous duct, and the opening of the acinus is connected with the small lactiferous duct.
At present, the probability of the disease of the mammary gland of a girl is very high, the treatment difficulty is high after the disease is suffered, the cost and money are more, and the patient can be suffered from great physical and mental pain, so that the health care work of the mammary gland is very important in daily life; at present, most female siblings tend to adopt a massage or moxibustion mode to keep the health of the mammary gland or treat the disease, but the existing moxibustion generally adopts a certain Chinese herbal medicine, so that the medicine effect is single, the medicine effect is poor, the treatment effect is not obvious, and the treatment time is long.
Disclosure of Invention
The traditional Chinese medicine composition has good curative effect and prevention effect on various diseases of the mammary gland, particularly has obvious treatment and health care effects and short treatment period by matching the traditional Chinese medicine composition with moxibustion, and simultaneously has simple preparation method, easy preparation conditions and popularization value.
The invention provides a technical scheme of a traditional Chinese medicine composition for breast health care, which comprises the following components, by weight, 22-25 parts of dandelion, 15-18 parts of prepared arisaema consanguineum schott, 10-15 parts of radix curcumae, 10-15 parts of angelica sinensis, 10-15 parts of selfheal, 10-15 parts of ligusticum wallichii, 10-15 parts of safflower and 10-15 parts of myrrh.
A traditional Chinese medicine composition for breast health care comprises, by weight, 23-24 parts of dandelion, 16-17 parts of prepared arisaema consanguineum schott, 12-14 parts of curcuma aromatica, 12-14 parts of angelica sinensis, 12-14 parts of selfheal, 12-14 parts of ligusticum wallichii, 12-14 parts of safflower and 12-14 parts of myrrh.
A traditional Chinese medicine composition for breast health care comprises, by weight, 23.5 parts of dandelion, 16.5 parts of prepared arisaema consanguineum schott, 13 parts of radix curcumae, 13 parts of angelica sinensis, 13 parts of selfheal, 13 parts of ligusticum wallichii, 13 parts of safflower and 13 parts of myrrh.
The medicinal value introduction of each component in the traditional Chinese medicine composition is as follows:
herba Taraxaci, which is rich in vitamin A, vitamin C and potassium, and also contains ferrum, calcium, vitamin B2, vitamin B1, magnesium, vitamin B6, folic acid and copper; the specific element content is mainly water, each 60 g of raw dandelion leaves contains 86 percent of water, 1.6 g of protein, 5.3 g of carbohydrate and 108.8 kilojoules of calories; the dandelion plant contains various healthy nutritional ingredients such as taraxol, taraxacin, choline, organic acid, inulin, etc.; sweet in nature and taste, slightly bitter and cold; entering liver and stomach meridians; has diuretic, laxative, jaundice treating, and gallbladder promoting effects; treating heat toxin, carbuncle swelling, pyocutaneous disease, internal carbuncle, conjunctival congestion, swelling and pain, damp-heat, jaundice, dribbling urination, pain, furuncle, acute mastitis, scrofula, toothache, conjunctival congestion, pharyngalgia, pulmonary abscess, intestinal abscess, damp-heat jaundice, stranguria with astringency and pain; it can be used for treating acute mastitis, lymphadenitis, lymphoid tuberculosis, furunculosis, acute conjunctivitis, common cold with fever, acute tonsillitis, acute bronchitis, gastritis, hepatitis, cholecystitis, and urinary tract infection.
The processed rhizoma arisaematis and the rhizoma arisaematis are bitter and pungent in flavor and warm in nature, and have the functions of eliminating dampness and phlegm, dispelling wind and arresting convulsion, dispersing lumps and dissipating binds, and relieving swelling and pain; the common clinical rhizoma arisaematis products comprise 3 kinds of raw rhizoma arisaematis, processed rhizoma arisaematis and Arisaema cum bile; raw arisaema root, rhizoma arisaematis is toxic, is usually used externally in clinic, and has good effects of relieving swelling and pain.
The turmeric root-tuber can promote qi circulation, break blood stasis and dredge channels and collaterals; can be used for treating blood stasis and qi stagnation, such as rheumatalgia, heart and abdomen pain, chest and hypochondrium pain, amenorrhea and abdominal pain, and traumatic injury; can break blood, dispel qi, and eliminate food stagnation, and can be used for treating amenorrhea, dysmenorrhea, and symptom stagnation; has effects in dispersing stagnated liver qi, relieving qi stagnation, activating qi-flowing, and removing blood stasis, and can be used for treating menoxenia, hepatitis, liver cirrhosis, cholecystitis, angina pectoris, epilepsy 30286, schizophrenia, etc..
Angelica sinensis, which is used for enriching blood, promoting blood circulation, regulating menstruation, relieving pain, moistening dryness and lubricating intestines; it is mainly indicated for blood deficiency syndromes, irregular menstruation, amenorrhea, dysmenorrhea, abdominal mass accumulation, metrorrhagia, abdominal pain due to deficiency-cold, flaccidity and paralysis, numbness of skin, intestinal dryness, difficulty in defecation, severe dysentery, carbuncle, sore and ulcer, and traumatic injury.
Spica Prunellae and Spica Prunellae are Chinese medicinal materials with heat and toxic materials clearing away effects, and have effects of treating conjunctival congestion, swelling and pain, headache, clearing liver fire, lowering blood pressure, resolving hard mass, relieving swelling, removing liver heat, and improving eyesight; spica Prunellae, with cold nature and entering liver meridian, can be used for purging liver fire to improve eyesight, and for treating conjunctival congestion and swelling and pain caused by liver fire flaming, it is often combined with folium Mori, flos Chrysanthemi, and semen Cassiae, and for eye disease pain caused by liver deficiency, it can be used with radix Angelicae sinensis; and (3) tumor resistance: the selfheal can clear liver fire and dissipate stagnation, is an important medicinal material for treating nodules and tumors caused by phlegm fire, and can play roles in softening hardness and dissipating stagnation, and preventing diseases such as goiter, scrofula, various tumors and the like; regulating blood pressure: the selfheal can delay the formation of atheromatous plaques in aorta, and has good curative effects of reducing blood fat and treating coronary heart disease, arteriosclerosis and the like.
Chuan Xiong, Chuan Xiong is called qi-moving medicine in blood, and has the functions of promoting qi circulation and relieving depression, promoting blood circulation and removing blood stasis, and relieving pain, and is commonly used for treating diseases, such as severe headache, and various wind-cold headache, migraine and vascular headache which are treated by Chuan Xiong for promoting qi circulation and relieving depression; is used for promoting blood circulation and removing blood stasis, and often treating gynecological diseases, menoxenia and amenorrhea; treating coronary heart disease, such as chest distress, breath holding, precordial pain; for treating some surgical diseases and traumatic injuries, Chuan Xiong is often used to promote qi and blood circulation.
Safflower, safflower is the dry flower of the safflower of the Compositae, the flower is picked from yellow to red in summer, dried in the shade or dried in the sun, the nature is pungent and warm, the flower enters the heart and liver channels, the efficacy is to promote blood circulation and dredge channels, dispel blood stasis and relieve pain, the clinical application is to the following symptoms: firstly, amenorrhea due to blood stagnation, dysmenorrhea, postpartum abdominal stagnant pain; second, abdominal mass; thirdly, chest stuffiness and pains, blood stasis and abdominal pain, hypochondriac pain; fourthly, the macula is dark in color due to stasis; fifthly, regurgitation, stasis headache, dizziness, apoplexy and hemiplegia, etc.
Myrrh and myrrh are medicines for promoting blood circulation and removing blood stasis, which belong to the heart channel, the liver channel and the spleen channel, are bitter and flat in nature and have the main effects of promoting blood circulation and relieving pain, promoting blood circulation and removing blood stasis, and eliminating swelling and promoting granulation, and are commonly used in the traditional Chinese medicine clinical: firstly, amenorrhea, dysmenorrhea, abdominal pain and abdominal pain of lower abdomen caused by blood stasis of women; the second is pain like the gastric cavity, especially due to gastric stasis; the third is hematoma and blood stasis caused by traumatic injury; the fourth is the skin or the internal abscess infection, the carbuncle swelling and the ulcer, the common myrrh is also used, the myrrh is often combined with incense for treating various blood stasis, and the pharmacological research at present thinks that the myrrh has the function of reducing blood fat, the function of resisting inflammation and the function of relieving pain, so the myrrh belongs to the blood activating medicine, and the blood activating medicine can activate blood circulation to dissipate blood stasis, is the medicine for dissipating blood stasis and relieving pain, and is the class of medicines for activating blood circulation to relieve pain.
Through the technical scheme, the dandelion is taken as a main component, and by utilizing various nutritional ingredients required by human bodies in the dandelion, particularly the excellent effect of the dandelion on treating acute mastitis, and the added rhizoma arisaematis preparata and radix curcumae, chinese angelica, selfheal, szechuan lovage rhizome, safflower and myrrh have respective treatment effects, the traditional Chinese medicine composition has various effects of preventing and treating female breast diseases through the mutual synergistic cooperation, so that the traditional Chinese medicine composition not only can have good treatment effect on the diseases when being used in cooperation with moxibustion, but also has good prevention effect on other diseases, embodies the health care effect of the traditional Chinese medicine composition, meanwhile, the medicinal effect of the prepared Chinese medicinal composition is further enhanced by controlling the dosage proportion of the components.
When in use, the powdered Chinese medicinal composition can be packaged in tea bag and soaked in water for drinking, or can be prepared into paste for external application.
Compared with the traditional Chinese medicine for treating the breast diseases, the traditional Chinese medicine composition has the advantages that the medicinal value of the traditional Chinese medicine composition is higher, the medicinal effect is better, the application range of the traditional Chinese medicine composition is wide, the traditional Chinese medicine composition has good curative effect on various diseases, the traditional Chinese medicine composition is easy to absorb by a patient, the treatment period is shortened, and the pain of the patient is reduced.
In order to achieve the above purpose, the present application also provides a preparation method of a traditional Chinese medicine composition for breast health care, which specifically comprises the following steps:
(1) removing impurities: cleaning the Chinese medicinal materials with clear water, and removing impurities;
(2) and (3) drying: drying the cleaned traditional Chinese medicine components by using a dryer;
(3) preparing materials: weighing the dried traditional Chinese medicine components according to the weight ratio for later use;
(4) crushing: adding the weighed traditional Chinese medicines into a pulverizer together for pulverizing to obtain a powdery traditional Chinese medicine mixture, and sieving to obtain the traditional Chinese medicine for breast health care.
Further, the drying temperature in the step (2) is 50-60 ℃, and the drying is carried out until the moisture content in the traditional Chinese medicine components is lower than 10%.
Further, in the step (4), a sieve with 80-100 meshes is adopted for sieving.
Based on the explanation, compared with the prior art, the technical scheme of the application has the advantages that:
(1) the traditional Chinese medicine composition has good curative effect and prevention effect on various diseases of mammary gland by mutual synergistic cooperation of the traditional Chinese medicine components and control of the dosage ratio of the traditional Chinese medicine components, and particularly, the traditional Chinese medicine composition is used in cooperation with moxibustion, so that the treatment and health care effects are obvious, and the treatment period is short;
(2) the traditional Chinese medicine composition is simple to operate in the preparation process, the preparation conditions are convenient to control, the preparation cost is low, and the industrial production is convenient to realize.
Detailed Description
Example 1
A traditional Chinese medicine composition for breast health care comprises, by weight, 22 parts of dandelion, 15 parts of rhizoma arisaematis preparata, 10 parts of radix curcumae, 10 parts of angelica sinensis, 10 parts of selfheal, 10 parts of ligusticum wallichii, 10 parts of safflower and 10 parts of myrrh.
The preparation method specifically comprises the following steps:
(1) removing impurities: cleaning the Chinese medicinal materials with clear water, and removing impurities;
(2) and (3) drying: drying the cleaned traditional Chinese medicine components by using a dryer, wherein the drying temperature is 50 ℃, and drying until the water content in the traditional Chinese medicine components is lower than 10%;
(3) preparing materials: weighing the dried traditional Chinese medicine components according to the weight ratio for later use;
(4) crushing: adding the weighed traditional Chinese medicines into a pulverizer together for pulverizing to obtain a powdery traditional Chinese medicine mixture, and sieving by using a 80-mesh sieve to obtain the traditional Chinese medicine for breast health care.
Example 2
A traditional Chinese medicine composition for breast health care comprises, by weight, 25 parts of dandelion, 18 parts of rhizoma arisaematis preparata, 15 parts of radix curcumae, 15 parts of angelica sinensis, 15 parts of selfheal, 15 parts of ligusticum wallichii, 15 parts of safflower and 15 parts of myrrh.
The preparation method specifically comprises the following steps:
(1) removing impurities: cleaning the Chinese medicinal materials with clear water, and removing impurities;
(2) and (3) drying: drying the cleaned traditional Chinese medicine components by using a dryer, wherein the drying temperature is 60 ℃, and drying until the water content in the traditional Chinese medicine components is lower than 10%;
(3) preparing materials: weighing the dried traditional Chinese medicine components according to the weight ratio for later use;
(4) crushing: adding the weighed traditional Chinese medicines into a pulverizer together for pulverizing to obtain a powdery traditional Chinese medicine mixture, and sieving by using a 100-mesh sieve to obtain the traditional Chinese medicine for breast health care.
Example 3
A traditional Chinese medicine composition for breast health care comprises, by weight, 23 parts of dandelion, 16 parts of rhizoma arisaematis preparata, 12 parts of radix curcumae, 12 parts of angelica sinensis, 12 parts of selfheal, 12 parts of ligusticum wallichii, 12 parts of safflower and 12 parts of myrrh.
The preparation method specifically comprises the following steps:
(1) removing impurities: cleaning the Chinese medicinal materials with clear water, and removing impurities;
(2) and (3) drying: drying the cleaned traditional Chinese medicine components by using a dryer, wherein the drying temperature is 55 ℃, and drying until the water content in the traditional Chinese medicine components is lower than 10%;
(3) preparing materials: weighing the dried traditional Chinese medicine components according to the weight ratio for later use;
(4) crushing: adding the weighed traditional Chinese medicines into a pulverizer together for pulverizing to obtain a powdery traditional Chinese medicine mixture, and sieving by using a sieve with 85 meshes to obtain the traditional Chinese medicine for the breast health care.
Example 4
A traditional Chinese medicine composition for breast health care comprises the following components, by weight, 24 parts of dandelion, 17 parts of rhizoma arisaematis preparata, 14 parts of radix curcumae, 14 parts of angelica sinensis, 14 parts of selfheal, 14 parts of ligusticum wallichii, 14 parts of safflower and 14 parts of myrrh.
The preparation method specifically comprises the following steps:
(1) removing impurities: cleaning the Chinese medicinal materials with clear water, and removing impurities;
(2) and (3) drying: drying the cleaned traditional Chinese medicine components by using a dryer, wherein the drying temperature is 50 ℃, and drying until the water content in the traditional Chinese medicine components is lower than 10%;
(3) preparing materials: weighing the dried traditional Chinese medicine components according to the weight ratio for later use;
(4) crushing: adding the weighed traditional Chinese medicines into a pulverizer together for pulverizing to obtain a powdery traditional Chinese medicine mixture, and sieving by using a 90-mesh sieve to obtain the traditional Chinese medicine for breast health care.
Example 5
A traditional Chinese medicine composition for breast health care comprises, by weight, 23.5 parts of dandelion, 16.5 parts of prepared arisaema consanguineum schott, 13 parts of radix curcumae, 13 parts of angelica sinensis, 13 parts of selfheal, 13 parts of ligusticum wallichii, 13 parts of safflower and 13 parts of myrrh.
The preparation method specifically comprises the following steps:
(1) removing impurities: cleaning the Chinese medicinal materials with clear water, and removing impurities;
(2) and (3) drying: drying the cleaned traditional Chinese medicine components by using a dryer, wherein the drying temperature is 60 ℃, and drying until the water content in the traditional Chinese medicine components is lower than 10%;
(3) preparing materials: weighing the dried traditional Chinese medicine components according to the weight ratio for later use;
(4) crushing: adding the weighed traditional Chinese medicines into a pulverizer together for pulverizing to obtain a powdery traditional Chinese medicine mixture, and sieving by using a 100-mesh sieve to obtain the traditional Chinese medicine for breast health care.
The above is only a preferred embodiment of the present invention, and it should be noted that the above preferred embodiment should not be considered as limiting the present invention, and the protection scope of the present invention should be subject to the scope defined by the claims. It will be apparent to those skilled in the art that various modifications and adaptations can be made without departing from the spirit and scope of the invention, and these modifications and adaptations should be considered within the scope of the invention.
Claims (6)
1. A traditional Chinese medicine composition for breast health care is characterized by comprising, by weight, 22-25 parts of dandelion, 15-18 parts of prepared arisaema consanguineum schott, 10-15 parts of radix curcumae, 10-15 parts of angelica sinensis, 10-15 parts of selfheal, 10-15 parts of ligusticum wallichii, 10-15 parts of safflower and 10-15 parts of myrrh.
2. The traditional Chinese medicine composition for breast health care according to claim 1, which comprises, by weight, 23-24 parts of dandelion, 16-17 parts of arisaema cum bile, 12-14 parts of curcuma aromatica, 12-14 parts of angelica sinensis, 12-14 parts of selfheal, 12-14 parts of ligusticum wallichii, 12-14 parts of safflower, and 12-14 parts of myrrh.
3. The traditional Chinese medicine composition for breast health care according to claim 1, which comprises, by weight, 23.5 parts of dandelion, 16.5 parts of rhizoma arisaematis preparata, 13 parts of radix curcumae, 13 parts of angelica sinensis, 13 parts of selfheal, 13 parts of ligusticum wallichii, 13 parts of safflower, and 13 parts of myrrh.
4. A preparation method of the traditional Chinese medicine composition for breast health care according to any one of claims 1 to 3, which is characterized by comprising the following steps:
(1) removing impurities: cleaning the Chinese medicinal materials with clear water, and removing impurities;
(2) and (3) drying: drying the cleaned traditional Chinese medicine components by using a dryer;
(3) preparing materials: weighing the dried traditional Chinese medicine components according to the weight ratio for later use;
(4) crushing: adding the weighed traditional Chinese medicines into a pulverizer together for pulverizing to obtain a powdery traditional Chinese medicine mixture, and sieving to obtain the traditional Chinese medicine for breast health care.
5. The preparation method of the traditional Chinese medicine composition for breast health care according to claim 4, wherein the drying temperature in the step (2) is 50-60 ℃, and the drying is carried out until the moisture content in the traditional Chinese medicine components is lower than 10%.
6. The preparation method of the Chinese medicinal composition for breast health care according to claim 4, wherein the screening is performed by using a 80-100 mesh screen in the step (4).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010666900.5A CN111686225A (en) | 2020-07-14 | 2020-07-14 | A Chinese medicinal composition for breast health protection, and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010666900.5A CN111686225A (en) | 2020-07-14 | 2020-07-14 | A Chinese medicinal composition for breast health protection, and its preparation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111686225A true CN111686225A (en) | 2020-09-22 |
Family
ID=72485429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010666900.5A Pending CN111686225A (en) | 2020-07-14 | 2020-07-14 | A Chinese medicinal composition for breast health protection, and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111686225A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113368200A (en) * | 2021-06-29 | 2021-09-10 | 王志萌 | A medicinal liquid for treating mastopathy, and its preparation method |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109820989A (en) * | 2019-04-11 | 2019-05-31 | 山东恒韶生物科技有限公司 | A kind of Chinese medicine fecula application and preparation method thereof for the proliferation of mammary gland |
-
2020
- 2020-07-14 CN CN202010666900.5A patent/CN111686225A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109820989A (en) * | 2019-04-11 | 2019-05-31 | 山东恒韶生物科技有限公司 | A kind of Chinese medicine fecula application and preparation method thereof for the proliferation of mammary gland |
Non-Patent Citations (2)
| Title |
|---|
| 孙杰: "中西医结合治疗乳腺增生症疗效观察", 《中国误诊学杂志》 * |
| 李成卫，等: "《恶性肿瘤名家传世灵验药对》", 31 March 2010, 中国医药科技出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113368200A (en) * | 2021-06-29 | 2021-09-10 | 王志萌 | A medicinal liquid for treating mastopathy, and its preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105030970A (en) | Health product for conditioning blood stasis constitution | |
| CN106387096A (en) | Health-care sesame oil and preparation method thereof | |
| CN111686225A (en) | A Chinese medicinal composition for breast health protection, and its preparation method | |
| CN103719616B (en) | Feed for treating bloody flux of pigs and preparation method of feed | |
| CN107184895A (en) | A kind of medicine for treating gall-bladder reflux gastritis and preparation method thereof | |
| CN113521211A (en) | Fruity tablet for improving uric acid metabolism of human body and preparation method thereof | |
| CN111467465A (en) | Heat-clearing composition and preparation process thereof | |
| CN105535820A (en) | Mongolian medicine swelling subsidence ointment | |
| CN110604782A (en) | Medicine for treating heart disease and preparation method thereof | |
| CN110898137A (en) | Pills for treating hyperthyroidism and preparation method and application thereof | |
| CN103705614B (en) | Traditional Chinese medicine for treating herpes zoster | |
| CN110507814B (en) | Suspension for treating yellow-white dysentery of young deer and using method thereof | |
| CN101318007A (en) | Traditional Chinese medicine capsule for esophagus cancer and stomach cancer | |
| CN114989927A (en) | Components suitable for preparing health-preserving health-care wine | |
| CN105853933A (en) | Traditional Chinese medicine preparation for treating postoperative recurrence and metastasis of breast cancer and preparing method | |
| CN105942049A (en) | Medicinal earthworm feed additive | |
| CN105233193A (en) | Traditional Chinese medicine treating coronary heart disease | |
| CN104825883A (en) | Traditional Chinese medicine prescription for treating rhinitis | |
| CN106822552A (en) | It is a kind of to treat medicine of rheumatoid arthritis and preparation method thereof | |
| CN103610815B (en) | A kind of Chinese medicine for the treatment of cellulitis | |
| CN113975362A (en) | External medicine composition for promoting wound healing and preparation method and application thereof | |
| CN117618518A (en) | An ancient method of removing cold and dampness and Mongolian medicine and its preparation method | |
| CN105878796A (en) | Vinegar beverage capable of treating type-II diabetes mellitus complicated with dyslipidemia and preparation method of vinegar beverage | |
| CN119345316A (en) | A kind of soft, dampness-removing and acid-removing granules and preparation method thereof | |
| CN105012641A (en) | Preparation for treating osteomyelitis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200922 |
|
| RJ01 | Rejection of invention patent application after publication |